Pershing Square Capital Management and Valeant Pharmaceuticals are paying $290 million to settle a lawsuit that alleged their trading in Allergan was illegal, allowing William Ackman to put behind him the last vestiges of an investment that created turmoil at his hedge fund.
from WSJ.com: US Business http://ift.tt/2DzOjIB
via IFTTT
No comments:
Post a Comment